Minimal residual disease response with venetoclax monotherapy in relapsed/refractory CLL patients: VENICE I, phase 3b exploratory analysis

Yazar
Aktan, Melih
Breuleux, Madlaina
Enggaard, Lisbeth
DEMİRKAN, FATİH
ARSLAN, ÖNDER
Turgut, Mehmet
Fort, Stan
Forconi, Francesco
Masud, Abdullah
Chyla, Brenda
Kater, Arnon
Panagiotis, Panayiotidis
Thornton, Patrick
Tempescul, Adrian
Skarbnik, Alan
Rossi, Davide
Montillo, Marco
Leber, Brian
Karlsson, Karin
Herishanu, Yair
Gonzalez Diaz, Marcos
Ferhanoglu, Burhan
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/99258
Koleksiyonlar